Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis.

Abstract

OBJECTIVES The present study was planned to investigate the relationship between the plasma lipid profile and disease activity in patients with a first clinical episode suggestive of multiple sclerosis (MS). MATERIAL AND METHODS Eighteen consecutive out-patients underwent a monthly brain magnetic resonance imaging (MRI), blood sample and neurological assessment over 6 months. Blood samples were used to evaluate total cholesterol and triglyceride levels as well as their lipoprotein fractions. Plasma total apolipoprotein E concentration was also determined. RESULTS We found a significant correlation between the mean number of enhancing lesions and the mean plasma level of both total and low density lipoprotein cholesterol. The total plasma cholesterol level increased on average by 4.4 mg/dl for each enhancing lesion. CONCLUSION Our preliminary data suggest a potential role of plasma cholesterol level as a biological marker of disease activity after a first demyelinating event. Further studies need, however, to be designed to determine whether the plasma cholesterol level is of practical use in monitoring the disease course.

020406080'05'06'07'08'09'10'11'12'13'14'15'16'17
Citations per Year

166 Citations

Semantic Scholar estimates that this publication has 166 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Giubilei2002BloodCA, title={Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis.}, author={Franco Giubilei and Giovanni Antonini and Silvia Di Legge and M. P. Sormani and Patrizia Pantano and Rafaela Antonini and Micaela Sepe-Monti and Francesca Caramia and Carlo Pozzilli}, journal={Acta neurologica Scandinavica}, year={2002}, volume={106 2}, pages={109-12} }